Summary
Successful exploitation of this vulnerability could allow an attacker to access privileged accounts.
Vulnerabilities 1
-
High 8.1
ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying…
Revision history
-
#1
ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products
References
-
ICS Advisory ICSMA-21-343-01 Web Version
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-343-01
-
Recommended Practices
https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01
-
Recommended Practices
https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
-
Recommended Practices
https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B